(Q38453644)

3 September 2017

1 reference

title

Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy (English)

1 reference

3 September 2017

1 reference

1 reference

1 reference

4

Caroline Telfer

1 reference

3 September 2017

Paul J Fairchild

1

1 reference

3 September 2017

Alison Leishman

2

1 reference

3 September 2017

Patty Sachamitr

3

1 reference

3 September 2017

Simon Hackett

5

1 reference

3 September 2017

Timothy J Davies

6

1 reference

3 September 2017

publication date

1 January 2015

1 reference

3 September 2017

published in

Regenerative Medicine

1 reference

3 September 2017

volume

10

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

275-286

1 reference

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

3 September 2017

cites work

1 reference

Establishment in culture of pluripotential cells from mouse embryos

21 January 2018

1 reference

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

21 January 2018

1 reference

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

Dendritic cell and macrophage heterogeneity in vivo

21 January 2018

1 reference

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

21 January 2018

1 reference

Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells

21 January 2018

1 reference

Langerhans cells renew in the skin throughout life under steady-state conditions

21 January 2018

1 reference

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

21 January 2018

1 reference

A therapeutic dendritic cell-based vaccine for HIV-1 infection

21 January 2018

1 reference

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.

21 January 2018

1 reference

Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients

21 January 2018

1 reference

Harnessing dendritic cells to generate cancer vaccines

21 January 2018

1 reference

Comparative study of clinical grade human tolerogenic dendritic cells

21 January 2018

1 reference

Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance

21 January 2018

1 reference

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

21 January 2018

1 reference

It's time to bring dendritic cell therapy to type 1 diabetes.

21 January 2018

1 reference

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

21 January 2018

1 reference

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters

21 January 2018

1 reference

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

The effect of human immunodeficiency virus-1 on monocyte-derived dendritic cell maturation and function.

21 January 2018

1 reference

Directed differentiation of dendritic cells from mouse embryonic stem cells.

21 January 2018

1 reference

Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro

21 January 2018

1 reference

Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions.

21 January 2018

1 reference

Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

21 January 2018

1 reference

Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

21 January 2018

1 reference

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells

21 January 2018

1 reference

Immunotherapy with pluripotent stem cell-derived dendritic cells

21 January 2018

1 reference

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.

21 January 2018

1 reference

Cell replacement therapy and the evasion of destructive immunity

21 January 2018

1 reference

Embryonic stem cells: a novel source of dendritic cells for clinical applications.

21 January 2018

1 reference

Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function

21 January 2018

1 reference

Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors

21 January 2018

1 reference

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

Stable lines of genetically modified dendritic cells from mouse embryonic stem cells.

21 January 2018

1 reference

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

21 January 2018

1 reference

Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination

21 January 2018

1 reference

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

21 January 2018

1 reference

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

21 January 2018

1 reference

New treatment approaches in melanoma: current research and clinical prospects

21 January 2018

1 reference

The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation

21 January 2018

1 reference

Cancer prevention with semi-allogeneic ES cell-derived dendritic cells

21 January 2018

1 reference

Innate and adaptive immune cells in the tumor microenvironment

21 January 2018

1 reference

Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression

21 January 2018

1 reference

Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies

21 January 2018

1 reference

T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures.

21 January 2018

1 reference

Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells

21 January 2018

1 reference

Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.

21 January 2018

1 reference

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity

21 January 2018

1 reference

A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells

21 January 2018

1 reference

How regulatory T cells work

21 January 2018

1 reference

Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.

21 January 2018

1 reference

Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.

21 January 2018

1 reference

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment

21 January 2018

1 reference

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease

21 January 2018

1 reference

Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease.

21 January 2018

1 reference

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

21 January 2018

1 reference

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

The tumorigenicity of human embryonic and induced pluripotent stem cells

21 January 2018

1 reference

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/RME.15.6

1 reference

3 September 2017

1 reference